Sustained Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients with Eosinophilic Esophagitis: Results from the Open-Label Extension of the Heroes Study

Authors
Category Primary study
JournalGastroenterology
Year 2018
This article has no abstract
Epistemonikos ID: 13c15ea5c4b422ce1c847755dc360e3ac0fbc2ba
First added on: Feb 11, 2025